This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: Market Opportunities

AIG is also investing heavily in technology, building a world-class platform that will provide the company with quality data and the ability to accurately project risk out into the future. This is something the regulators will be happy to see, Benmosche added.

Cramer said AIG is the cheapest of all the insurers he follows.

More 'Final Four'

For the second installment of his "Final Four" tribute to NCAA basketball's "March Madness," Cramer moved to the Nasdaq bracket where the contenders, Intercept Pharmaceuticals (ICPT - Get Report) and Fuel Cell Technologies (PLUG - Get Report) were duking it out to see which makes the final matchup Friday.

Cramer said any investors who own these stocks have had a remarkable run and should sell three-quarters of their positions to lock in their gains.

Must Read: Jim Cramer's 'Mad Money' Recap: Out With a Bang

As for the matchup, Cramer said Intercept's liver disease treatments are very promising and their orphan status with the Food and Drug Administration makes them very attractive. That said, approvals for the company's first and second drugs are pretty much priced into the stock at these valuations.

Fuel Cell, on the other hand, has a sizable backlog of orders for its forklift power systems, with a notable customer that's none other than Wal-Mart (WMT). This company needs a steady stream of positive news to keep it going, said Cramer, which makes it worrisome.

After careful evaluation of both companies, Cramer said he's declaring Intercept the winner in the Nasdaq bracket, and the company will face off against last night's winner, oil driller Nabors Industries (NBR).

Lightning Round

In the Lightning Round, Cramer was bullish on Suncor Energy (SU), First Solar (FSLR), Chicago Bridge & Iron (CBI), Cheniere Energy (LNG) and Priceline Group (PCLN).

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AIG $62.08 0.00%
ICPT $241.17 0.00%
PLUG $2.32 0.00%
AAPL $126.44 0.00%
FB $87.28 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs